Literature DB >> 22327732

Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes.

Andina Hu1, Yan Luo, Tao Li, Xiaobo Guo, Xiaoyan Ding, Xiaobo Zhu, Xueqin Wang, Shibo Tang.   

Abstract

BACKGROUND: The association between lipids and diabetic retinopathy (DR) remains unclear. Only a few studies have reported the association between proliferative diabetic retinopathy (PDR) and the serum concentrations of apolipoprotein A1 (apoA1), apolipoprotein B (apoB) and apolipoprotein E (apoE). So we investigated the lipid profile in type 2 diabetic patients of long duration with very mild nonproliferative diabetic retinopathy (NPDR) or PDR.
METHODS: Serum samples were obtained from 25 type 2 diabetic patients with very mild NPDR and 25 type 2 diabetic patients with PDR, and the two groups were matched by diabetes duration and glycosylated hemoglobin (HbA(1c)) levels. The levels of total cholesterol, triglycerides, LDL cholesterol, HDL cholesterol, apoA1, apoB, and apoE were measured by enzymatic colorimetric, surfactant, and immunotubidimetric method.
RESULTS: Compared with PDR subjects, very mild NPDR subjects were characterized by increased HDL cholesterol (P = 0.0433) and apoA1 (P = 0.0290) levels, higher HDL cholesterol/LDL cholesterol (P = 0.0377) and apoA1/apoB (P = 0.0061) ratio in serum. There were significant associations between the decreased apoA1 and low apoA1/apoB ratio in serum and PDR. Even after adjustment for age, decreased apoA1 level (P = 0.0304) and low apoA1/apoB ratio (P = 0.0218) in serum were significantly associated with PDR in type 2 diabetic patients of over 15 years' duration.
CONCLUSIONS: Low apolipoprotein A1/apolipoprotein B ratio in serum was associated with PDR in type 2 diabetic patients of long duration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22327732     DOI: 10.1007/s00417-011-1855-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  30 in total

1.  High-density lipoproteins prevent the oxidized low-density lipoprotein-induced epidermal [corrected] growth factor receptor activation and subsequent matrix metalloproteinase-2 upregulation.

Authors:  Fanny Robbesyn; Nathalie Augé; Cécile Vindis; Anne-Valérie Cantero; Ronald Barbaras; Anne Negre-Salvayre; Robert Salvayre
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-07       Impact factor: 8.311

2.  Magnetic navigation system assisted percutaneous coronary intervention: a comparison to the conventional approach in daily practice.

Authors:  Chun-Jian Li; Hui Wang; Zhi-Jian Yang; Ke-Jiang Cao
Journal:  Chin Med J (Engl)       Date:  2011-01       Impact factor: 2.628

Review 3.  Insulin and lipoprotein metabolism with special reference to the diabetic state.

Authors:  G H Tomkin; D Owens
Journal:  Diabetes Metab Rev       Date:  1994-10

4.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

Review 5.  Hyperlipidaemia in diabetes.

Authors:  M R Taskinen
Journal:  Baillieres Clin Endocrinol Metab       Date:  1990-12

6.  A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes.

Authors:  Biljana Miljanovic; Robert J Glynn; David M Nathan; Joann E Manson; Debra A Schaumberg
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

7.  Association of serum lipids with diabetic retinopathy in urban South Indians--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--2.

Authors:  M Rema; B K Srivastava; B Anitha; R Deepa; V Mohan
Journal:  Diabet Med       Date:  2006-09       Impact factor: 4.359

8.  Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

Authors:  A C Keech; P Mitchell; P A Summanen; J O'Day; T M E Davis; M S Moffitt; M-R Taskinen; R J Simes; D Tse; E Williamson; A Merrifield; L T Laatikainen; M C d'Emden; D C Crimet; R L O'Connell; P G Colman
Journal:  Lancet       Date:  2007-11-07       Impact factor: 79.321

9.  Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched study.

Authors:  O James Ekundayo; Chris Adamopoulos; Mustafa I Ahmed; Bertram Pitt; James B Young; Jerome L Fleg; Thomas E Love; Xuemei Sui; Gilbert J Perry; David S Siscovick; George Bakris; Ali Ahmed
Journal:  Int J Cardiol       Date:  2009-01-09       Impact factor: 4.164

10.  Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.

Authors:  J R Schultz; J G Verstuyft; E L Gong; A V Nichols; E M Rubin
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

View more
  9 in total

Review 1.  Dyslipidemia and diabetic retinopathy.

Authors:  Yo-Chen Chang; Wen-Chuan Wu
Journal:  Rev Diabet Stud       Date:  2013-08-10

2.  Retinopathy in non diabetics, diabetic retinopathy and oxidative stress: a new phenotype in Central Africa?

Authors:  Benjamin Longo-Mbenza; Moise Mvitu Muaka; Wayiza Masamba; Lucien Muizila Kini; Igor Longo Phemba; Dalida Kibokela Ndembe; Doris Tulomba Mona
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

3.  Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy.

Authors:  Roxanne Crosby-Nwaobi; Irini Chatziralli; Theodoros Sergentanis; Tracy Dew; Angus Forbes; Sobha Sivaprasad
Journal:  J Diabetes Res       Date:  2015-07-29       Impact factor: 4.011

4.  Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy.

Authors:  Jianqing Li; Qianyi Lu; Peirong Lu
Journal:  BMC Ophthalmol       Date:  2018-06-26       Impact factor: 2.209

5.  Associations between serum apolipoproteins, urinary albumin excretion rate, estimated glomerular filtration rate, and diabetic retinopathy in individuals with type 2 diabetes.

Authors:  Jin Ook Chung; Seon-Young Park; Dong Hyeok Cho; Dong Jin Chung; Min Young Chung
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

6.  Association of Glycated Haemoglobin and Serum Apolipoproteins with Diabetic Retinopathy: An Indian Overview.

Authors:  Bhasker Mukherjee; Sandeep Shankar; Rehan Ahmed; Kanchan Singh; Kapil Bhatia
Journal:  J Clin Diagn Res       Date:  2017-09-01

Review 7.  Does tight control of systemic factors help in the management of diabetic retinopathy?

Authors:  Ramachandran Rajalakshmi; Vijayaraghavan Prathiba; Viswanathan Mohan
Journal:  Indian J Ophthalmol       Date:  2016-01       Impact factor: 1.848

8.  The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes.

Authors:  Sangeeta Kashyap; Karim Kheniser; Ling Li; James Bena; Takhar Kasumov
Journal:  Lipids Health Dis       Date:  2016-08-27       Impact factor: 3.876

9.  Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus.

Authors:  Michael Müller; Carl-Ludwig Schönfeld; Tanja Grammer; Vera Krane; Christiane Drechsler; Bernd Genser; Thomas Kohnen; Christoph Wanner; Winfried März
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.